Form4insider filings, from the source

SEC Form 4 · accession 0001106578-26-000118

UNITED THERAPEUTICS Corp · UTHR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Martine A Rothblatt
Officer — Chairperson & CEO · Director
Period of report
Aug 11, 2026
Accepted (ET)
Aug 12, 2026 · 4:30 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001082554

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Aug 11, 2026M9,500$135.42A333,943Iby Trust
Common StockF3,F2Aug 11, 2026S475$513.3718D333,468Iby Trust
Common StockF4,F2Aug 11, 2026S1,214$514.5247D332,254Iby Trust
Common StockF5,F2Aug 11, 2026S360$515.5153D331,894Iby Trust
Common StockF6,F2Aug 11, 2026S520$516.9114D331,374Iby Trust
Common StockF7,F2Aug 11, 2026S120$517.57D331,254Iby Trust
Common StockF8,F2Aug 11, 2026S120$518.9528D331,134Iby Trust
Common StockF9,F2Aug 11, 2026S200$520.5934D330,934Iby Trust
Common StockF10,F2Aug 11, 2026S200$521.7333D330,734Iby Trust
Common StockF11,F2Aug 11, 2026S221$523.0364D330,513Iby Trust
Common StockF12,F2Aug 11, 2026S379$524.1343D330,134Iby Trust
Common StockF13,F2Aug 11, 2026S871$525.192D329,263Iby Trust
Common StockF14,F2Aug 11, 2026S2,725$526.0482D326,538Iby Trust
Common StockF15,F2Aug 11, 2026S935$527.1606D325,603Iby Trust
Common StockF16,F2Aug 11, 2026S737$528.0676D324,866Iby Trust
Common StockF17,F2Aug 11, 2026S143$529.0518D324,723Iby Trust
Common StockF18,F2Aug 11, 2026S280$531.0106D324,443Iby Trust
Common Stockholding———40,513D
Common Stockholding———166Iby Spouse
Common StockF19holding———249,108Iby Trust
Common StockF20holding———45,596Iby Trust
Common StockF21holding———8,902Iby Trust

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock OptionF22$135.42Aug 11, 2026M9,500DMar 15, 2023Mar 15, 2027Common Stock9,500160,910I

Explanation of responses